Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/11 06:04 | 8/9/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S.m | -340 | 2.08 | 0 | -163 | -100 | 0 | I | -72 | -66 | -59 | -28 | 18 | 23 | -12 | -13 | -5 | -15 | -20 | -39 | -72 | |
8/11/11 10:38 | 8/9/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -340 | 2.08 | 0 | -163 | -100 | 0 | I | -77 | -71 | -65 | -40 | -2 | 6 | -24 | -26 | 17 | 2 | -6 | -27 | -54 | |
6/28/11 08:54 | 6/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -18 | 2.10 | 1 | -9 | -5 | 163 | I | -67 | -72 | -70 | -49 | -28 | -4 | -22 | 14 | -4 | -17 | -1 | -25 | -50 | |
6/28/11 08:50 | 6/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S.m | -18 | 2.10 | 1 | -9 | -5 | 163 | I | -67 | -72 | -70 | -49 | -28 | -4 | -22 | 14 | -4 | -17 | -1 | -25 | -50 | |
6/27/11 08:35 | 6/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S | -105 | 2.09 | 1 | -50 | -23 | 172 | I | -64 | -72 | -71 | -51 | -29 | -5 | -26 | 13 | 0 | -14 | -12 | -21 | -54 | |
6/27/11 08:33 | 6/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -105 | 2.09 | 1 | -50 | -23 | 172 | I | -64 | -72 | -71 | -51 | -29 | -5 | -26 | 13 | 0 | -14 | -12 | -21 | -54 | |
6/23/11 13:07 | 6/16/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.a | -1,253 | 3.14 | 0 | -399 | -51 | 385 | I | -70 | -78 | -75 | -56 | -41 | -26 | 7 | -16 | 18 | 3 | -3 | -4 | -49 | |
6/20/11 08:38 | 6/16/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S | -961 | 3.20 | 0 | -300 | -57 | 222 | I | -69 | -75 | -69 | -40 | -32 | -19 | 4 | 28 | -9 | -4 | -20 | -23 | -52 | |
6/20/11 07:57 | 6/16/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -1,253 | 3.14 | 0 | -399 | -61 | 255 | I | -69 | -75 | -69 | -40 | -32 | -19 | 4 | 28 | -9 | -4 | -20 | -23 | -52 | |
6/6/11 08:19 | 6/2/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -49 | 2.34 | 0 | -21 | -7 | 262 | I | -64 | -70 | -61 | -40 | -33 | -21 | -11 | -15 | -5 | -20 | -25 | -21 | -54 | |
6/2/11 09:52 | 6/1/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -27 | 2.46 | 0 | -11 | -4 | 283 | I | -60 | -69 | -55 | -29 | -24 | -18 | -10 | -7 | -2 | -17 | -27 | -26 | -60 | |
5/19/11 16:19 | 5/17/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | EVP Rese | S.m | -7 | 2.77 | 0 | -2 | -33 | 5 | D | -41 | -66 | -53 | -36 | -26 | -17 | -5 | 2 | -6 | -10 | -26 | -37 | -62 | |
5/16/11 21:05 | 5/12/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | EVP Rese | S.m | -8 | 2.85 | 0 | -3 | -26 | 7 | D | -33 | -70 | -58 | -44 | -29 | -20 | -8 | -9 | 1 | -4 | -41 | -29 | -58 | |
3/30/11 09:50 | 3/28/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -50 | 4.07 | 0 | -12 | -4 | 294 | I | 22 | -60 | -42 | -40 | -20 | 2 | 10 | -5 | 5 | 2 | -10 | -50 | -69 | |
3/28/11 12:05 | 3/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -616 | 4.03 | 0 | -153 | -23 | 522 | I | 18 | -56 | -39 | -42 | -20 | 7 | 26 | 7 | -3 | -3 | -14 | -51 | -61 | |
3/28/11 12:03 | 3/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S.m | -616 | 4.03 | 0 | -153 | -23 | 522 | I | 18 | -56 | -39 | -42 | -20 | 7 | 26 | 7 | -3 | -3 | -14 | -51 | -61 | |
3/25/11 18:03 | 3/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -135 | 4.01 | 0 | -34 | -3 | 981 | I | 24 | -58 | -39 | -42 | -20 | 9 | 19 | 8 | -3 | 0 | -13 | -50 | -61 | |
3/25/11 18:01 | 3/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S | -49 | 4.01 | 0 | -12 | -2 | 675 | I | 24 | -58 | -39 | -42 | -20 | 9 | 19 | 8 | -3 | 0 | -13 | -50 | -61 | |
3/2/11 11:26 | 2/28/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -52 | 3.67 | 0 | -14 | -4 | 328 | I | 194 | -55 | -40 | -39 | -41 | -31 | -16 | -10 | -3 | 4 | 15 | -26 | -47 | -83 |
7/29/10 11:20 | 11/11/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -220 | 8.32 | 0 | -26 | -3 | 820 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
5/26/10 13:19 | 5/24/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | S | -16 | 8.07 | 1 | -2 | -17 | 10 | D | 116 | 29 | -9 | -2 | -19 | -23 | -19 | -2 | -1 | 1 | 0 | -26 | -24 | -68 | |
5/21/10 13:14 | 5/19/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | S | -13 | 8.71 | 1 | -2 | -11 | 12 | D | 121 | 47 | -11 | 2 | -15 | -22 | -23 | -15 | 2 | 2 | -2 | -27 | -23 | -64 | |
5/5/10 15:56 | 5/3/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Svlsf Iv, LLC | MA | T | S | -3,075 | 10.25 | 1 | -300 | -83 | 61 | D | 230 | 242 | 26 | 37 | 18 | 4 | 9 | -1 | 1 | 2 | -22 | -31 | -30 | -68 | |
12/1/09 18:53 | 11/30/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | Chief Me | S.d | -97 | 8.07 | 1 | -12 | -64 | 7 | D | 15 | 628 | 34 | 8 | 0 | 3 | -6 | -5 | 4 | -9 | -4 | -4 | -4 | -34 |
11/30/09 20:38 | 11/25/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | Chief Me | S.dm | -83 | 8.38 | 1 | -10 | -60 | 7 | D | 15 | 571 | 41 | 6 | -1 | 11 | -9 | -6 | 1 | -3 | -5 | -5 | -7 | -29 |
11/23/09 13:33 | 11/19/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | S.m | -50 | 8.28 | 1 | -6 | -31 | 14 | D | 38 | 445 | 42 | 17 | 3 | 7 | 2 | -4 | 1 | -5 | -12 | -7 | -9 | -31 | |
9/17/09 16:19 | 9/15/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Svlsf Iv, LLC | MA | T | S | -14,760 | 8.00 | 1 | -1,845 | -42 | 2,591 | S | -1 | -1 | -2 | -11 | 1 | -23 | |||||||||
8/21/09 19:19 | 8/20/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | S | -7 | 7.22 | 1 | -1 | -5 | 20 | D | 5 | 127 | 437 | 52 | 21 | -8 | -5 | 0 | 0 | 5 | 11 | 18 | 7 | -22 | |
8/17/09 19:36 | 8/14/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | S.m | -49 | 7.25 | 1 | -7 | -25 | 21 | D | 6 | 134 | 416 | 52 | 25 | -17 | -8 | -4 | -1 | 0 | 15 | 13 | 3 | -16 | |
8/14/09 16:00 | 8/12/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | S.m | -42 | 7.39 | 1 | -6 | -17 | 27 | D | 4 | 137 | 383 | 74 | 24 | -18 | -9 | -7 | 0 | 0 | 6 | 14 | 1 | -20 | |
7/15/09 16:30 | 7/13/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S | -1,493 | 5.97 | 1 | -250 | -14 | 1,526 | I | -19 | 89 | 395 | 168 | 8 | 10 | 10 | 8 | 2 | 15 | 11 | 23 | 8 | 10 |
7/10/09 17:23 | 7/8/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -140 | 5.92 | 1 | -24 | -1 | 1,776 | I | -27 | 83 | 301 | 142 | 8 | -11 | 0 | 2 | -1 | 13 | 30 | 33 | 20 | 23 |
7/8/09 17:27 | 7/6/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -323 | 5.93 | 1 | -54 | -3 | 1,799 | I | -28 | 82 | 348 | 117 | -2 | -10 | 7 | -1 | -1 | 8 | 34 | 34 | 24 | 20 |
7/1/09 18:19 | 6/26/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -1,615 | 5.87 | 1 | -275 | -13 | 1,854 | I | -34 | 87 | 289 | 82 | 18 | -9 | -15 | 3 | 0 | 2 | 50 | 41 | 31 | 14 |
6/25/09 10:01 | 6/22/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -520 | 6.24 | 0 | -83 | -4 | 2,129 | I | -29 | 85 | 317 | 79 | 54 | -4 | -8 | -13 | -6 | 1 | 53 | 41 | 28 | 32 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |